Evidence map›Paper›PMID 36165699›Full record

ArticleToxicological sciences : an official journal of the Society of Toxicology2022

A Transformative Vision for an Omics-Based Regulatory Chemical Testing Paradigm.

Kamin J Johnson, Scott S Auerbach, Tina Stevens, Tara S Barton-Maclaren, Eduardo Costa, Richard A Currie, Deidre Dalmas Wilk, Saddef Haq, Julia E Rager, Anthony J F Reardon and 6 more

Open access · hybridAbstract read
In one paragraph

Article in Toxicological sciences : an official journal of the Society of Toxicology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
18.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 87 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Analytical choices drive toxicogenomic potency estimates: a systematic evaluation of transcriptomic points of departure.Toxicological sciences : an official journal of the Society of Toxicology · 2026
    Article
  5. Article
  6. Article
  7. Progeny effects of rotenone exposure depend on parental toxicity.Toxicological sciences : an official journal of the Society of Toxicology · 2026
    Article
  8. Review
  9. Application ofFrontiers in toxicology · 2026
    Review
  10. Article
  11. ARACRA: Automated RNA-seq Analysis for Chemical Risk Assessment.Computational and structural biotechnology journal · 2026
    Article
  12. Review
  13. Article
  14. Article
  15. Navigating complexity in modern toxicology: the role of omics in short-term in vivo studies.Toxicological sciences : an official journal of the Society of Toxicology · 2025
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. A workflow for human health hazard evaluation using transcriptomic data and Key Characteristics-based gene sets.Toxicological sciences : an official journal of the Society of Toxicology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 11 institutions in 3 countries.

Kamin J JohnsonPredictive Safety Center, Corteva Agriscience, Indianapolis, Indiana 46268, USA.ORCID 0000-0003-4550-5566
Scott S AuerbachPredictive Toxicology Branch, Division of the Translational Toxicology, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina 27709, USA.ORCID 0000-0002-6294-3069
Tina StevensDrug Safety and Drug Metabolism and Pharmacokinetics, Boehringer-Ingelheim, Athens, Georgia 30601, USA.
Tara S Barton-MaclarenHealthy Environments and Consumer Safety Branch, Health Canada, Ottawa, Ontario K1P 5J9, Canada.
Eduardo CostaPredictive Safety Center, Corteva Agriscience, Indianapolis, Indiana 46268, USA.
Richard A CurrieProduct Safety, Syngenta Jealotts Hill International Research Center, Bracknell RG42 6EY, UK.ORCID 0000-0002-6528-3326
Deidre Dalmas WilkInvestigative Safety, In vitro In Vivo Translation, GlaxoSmithKline, Collegeville, Pennsylvania 19426, USA.
Saddef HaqHealth and Environmental Sciences Institute, Washington, District of Columbia 20005, USA.ORCID 0000-0002-5274-6299
Julia E RagerThe Department of Environmental Sciences and Engineering, Gillings School of Global Public Health, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA.ORCID 0000-0002-2882-5042
Anthony J F ReardonHealthy Environments and Consumer Safety Branch, Health Canada, Ottawa, Ontario K1P 5J9, Canada.ORCID 0000-0002-7124-1229
Leah WehmasU.S. Environmental Protection Agency, Office of Research and Development, Center for Computational Toxicology and Exposure, Research Triangle Park, North Carolina 27711, USA.ORCID 0000-0003-1529-2387
Andrew WilliamsHealthy Environments and Consumer Safety Branch, Health Canada, Ottawa, Ontario K1P 5J9, Canada.
Jason O'BrienWildlife Toxicology Research Section, Environment and Climate Change Canada, Ottawa, Ontario K1A 0H3, Canada.
Carole YaukDepartment of Biology, University of Ottawa, Ottawa, Ontario K1N 6N5, Canada.
Jessica L LaRoccaPredictive Safety Center, Corteva Agriscience, Indianapolis, Indiana 46268, USA.
Syril PettitHealth and Environmental Sciences Institute, Washington, District of Columbia 20005, USA.
Corteva (United States) · USHealth Canada · CAHealth and Environmental Sciences Institute · USBoehringer Ingelheim (United States) · USEnvironmental Protection Agency · USEnvironment and Climate Change Canada · CAGlaxoSmithKline (United States) · USNational Institute of Environmental Health Sciences · USSyngenta (United Kingdom) · GBUniversity of North Carolina at Chapel Hill · USUniversity of Ottawa · CA

Funding

UNC-CH CENTER FOR ENVIRONMENTAL HEALTH &SUSCEPTIBILITYP30ES010126 · NIEHS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Hazel B Nichols · 2001 to 2026
$36.3M
The UNC Chapel Hill Superfund Research Program (UNC-SRP)P42ES031007 · NIEHS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Kathleen M Gray · 2020 to 2026
$22.2M
NIEHS NIH HHS P30 ES010126NIEHS NIH HHS P42 ES031007
6 · The paper itself

Abstract

Use of molecular data in human and ecological health risk assessments of industrial chemicals and agrochemicals has been anticipated by the scientific community for many years; however, these data are rarely used for risk assessment. Here, a logic framework is proposed to explore the feasibility and future development of transcriptomic methods to refine and replace the current apical endpoint-based regulatory toxicity testing paradigm. Four foundational principles are outlined and discussed that would need to be accepted by stakeholders prior to this transformative vision being realized. Well-supported by current knowledge, the first principle is that transcriptomics is a reliable tool for detecting alterations in gene expression that result from endogenous or exogenous influences on the test organism. The second principle states that alterations in gene expression are indicators of adverse or adaptive biological responses to stressors in an organism. Principle 3 is that transcriptomics can be employed to establish a benchmark dose-based point of departure (POD) from short-term, in vivo studies at a dose level below which a concerted molecular change (CMC) is not expected. Finally, Principle 4 states that the use of a transcriptomic POD (set at the CMC dose level) will support a human health-protective risk assessment. If all four principles are substantiated, this vision is expected to transform aspects of the industrial chemical and agrochemical risk assessment process that are focused on establishing safe exposure levels for mammals across numerous toxicological contexts resulting in a significant reduction in animal use while providing equal or greater protection of human health. Importantly, these principles and approaches are also generally applicable for ecological safety assessment.

Indexed as

Toxicity TestsTranscriptomeAnimalsBenchmarkingHumansMammalsRisk Assessmentpoint of departurerisk assessmenttoxicogenomicstranscriptomics

Identifiers

PMID36165699
PMCPMC9702989
OpenAlexW4297261109

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.